New eye drops aim to ease pain after laser surgery

NCT ID NCT07412496

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This Phase 2 trial tests whether BL1332 eye drops can reduce pain after PRK laser eye surgery. About 123 adults will receive either a low or high dose of the drops or a placebo, applied five times a day. The study is double-masked, meaning neither patients nor doctors know who gets the real treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
BL1332 eye drops
What this could lead to
If it works, this could provide a new option to ease pain after PRK eye surgery.
What could go wrong
This is an early Phase 2 trial with only 123 people. The treatment may not work better than a placebo, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAIN, POSTOPERATIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.